Johnson & Johnson and Merck on Monday
announced plans to buy cancer therapy developers on the first
day of a major U.S. healthcare conference, igniting what
industry participants hope will be a strong.
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout.